Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 10, 2013 07:30 ET | Source: Raptor Pharmaceutical Inc

Raptor Submits IND for RP103 for Leigh Syndrome and Other Mitochondrial Disorders

NOVATO, Calif., Dec. 10, 2013 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that it has submitted an investigational new drug application (IND) to the U.S. Food and...